Anästhesiol Intensivmed Notfallmed Schmerzther 2011; 46(9): 560-567
DOI: 10.1055/s-0031-1286606
Fachwissen
Anästhesie / Intensivmedizin
© Georg Thieme Verlag Stuttgart · New York

Prävention der ventilatorassoziierten Pneumonie – Was ist evidenzbasiert?

Prevention of ventilator-associated pneumonia – What's evidence-based treatment?
Maria Deja
,
Tanja Trefzer
,
Christine Geffers
Further Information

Publication History

Publication Date:
05 September 2011 (online)

Zusammenfassung

Die ventilatorassoziierte Pneumonie (VAP) ist eine häufige Infektion in der Intensivmedizin. Typischerweise werden Erreger aus dem oberen Respirationstrakt entlang des Beatmungstubus am Cuff vorbei aspiriert und verursachen eine Pneumonie. Die Kolonisation des oropharyngealen Raums mit Erregern und der Verlust der Autonomie des Patienten durch Krankheit und notwendige Analgosedierung sind Trigger für die ventilatorassoziierte Pneumonie. Moderne Behandlungsstrategien zur Vermeidung invasiver Beatmung (z.B. Übersedierung) und einer Besiedelung mit typischen nosokomialen Erregern (z.B. orale Dekontamination, Händedesinfektion) sowie moderne technische Möglichkeiten zur Vermeidung der Mikroaspiration (z.B. subglottische Absaugung) sind nur einige einer Vielzahl von Präventionsmaßnahmen. Eine erfolgreiche Prävention verkürzt die Beatmungsdauer, den Intensiv- und Krankenhausaufenthalt und reduziert Kosten. In Studien wird eine bessere Überlebensrate diskutiert und eine bis zu 10 % geringere Sterblichkeit angegeben. VAP kann jedoch nicht immer vermieden werden. Dieser Beitrag geht auf die Problematik der evidenzbasierten Beurteilung der Präventionsmaßnahmen ein und stellt ausgewählte Präventionsmaßnahmen bzgl. ihrer Wirkungsweise und Wirksamkeit dar.

Summary

Patients who suffer from a ventilator-associated pneumonia (VAP) are ventilated longer, stay longer in the ICU and in hospital and therefore lead to higher costs. Despite the therapeutic potential of the VAP nowadays there is about 10% additional mortality observed. Although the clinical VAP diagnosis is limited (sensitivity/specificity) rapid diagnosis promotes treatment (calculated antibiotic therapy) and improves the survival rate. And in the course the review of the VAP diagnosis of unnecessary antibiotics reduces the resistance development in that area and also the selection pressure.

Just because the development of VAP cannot be prevented to 100%, it is an important step to avoid unnecessary mechanical ventilation to reduce the risk of VAP.

Many of the actions have already shown positive effects on the incidence of VAP and are presented here. To promote the implementation of individual actions in clinical practice, the measures should be propagated as "bundle" and promoted in trainings. The individual "bundle" of a hospital depends on the documented evidence of a measure of outcome-based parameters and in the local circumstances in terms of risk profile of patients, local needs and the human and structural possibilities of an institution.

Kernaussagen

  • Patienten mit einer ventilatorassoziierten Pneumonie (VAP) werden länger beatmet, verbleiben länger auf der Intensivstation und im Krankenhaus und verursachen höhere Kosten.

  • Eine kürzere Beatmungsdauer verringert auch das Risiko einer VAP.

  • Die frühzeitige Verdachtsdiagnose und die Einleitung einer zeitnahen Antibiotikatherapie sind wichtig für das Überleben der Patienten – trotz geringer Spezifität der Diagnose.

  • Für die Beurteilung der Evidenz einer Präventionsmaßnahme sind zusätzliche Outcome-Parameter wie die Verkürzung der Beatmungsdauer und des Intensivstations- oder Krankenhausaufenthalts überzeugender als ”lediglich“ die Reduktion der VAP-Rate.

  • Zu evidenzbasierten Präventionsmaßnahmen gehören v. a. Händedesinfektion, orale Mundpflege, subglottische Absaugung, Sedierungs- und Weaningprotokolle sowie Fortbildungen und ”bundles“.

  • Nicht mit ausreichender Evidenz belegte Maßnahmen sind u. a. selektive Darmdekontamination und selektive orale Dekontamination, Ulkusprophylaxe und Ernährungsregime.

Ergänzendes Material

 
  • Literaturverzeichnis

  • 1 Rotstein C, Evans G, Born A et al. Clinical practice guidelines for hospital-acquired pneumonia and ventilator-associated pneumonia in adults. Can J Infect Dis Med Microbiol 2008; 19: 19-53
  • 2 Niederman MS, Craven DE, Bonten MJ et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171: 388-416
  • 3 Masterton RG, Galloway A, French G et al. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the working party on hospital-acquired pneumonia of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2008; 62: 5-34
  • 4 Heyland DK, Cook DJ, Griffith L et al. The attributable morbidity and mortality of ventilator-associated pneumonia in the critically ill patient. The Canadian Critical Trials Group. Am J Respir Crit Care Med 1999; 159: 1249-1256
  • 5 Rello J, Ollendorf DA, Oster G et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122: 2115-2121
  • 6 Warren DK, Shukla SJ, Olsen MA et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med 2003; 31: 1312-1317
  • 7 Zuschneid I, Geffers C, Sohr D et al. Trends in ventilator-associated pneumonia rates within the German nosocomial infection surveillance system (KISS). Infect Control Hosp Epidemiol 2007; 28: 314-318
  • 8 Luna CM, Vujacich P, Niederman MS et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111: 676-685
  • 9 Cook DJ, Walter SD, Cooket RC et al. Canadian Critical Care Trials Group.. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998; 129: 433-440
  • 10 Safdar N, Dezfulian C, Collard HR, Saint S. Clinical and economic consequences of ventilator-associated pneumonia: a systematic review. Crit Care Med 2005; 33: 2184-2193
  • 11 Papazian L, Bregeon F, Thirionet X et al. Effect of ventilator-associated pneumonia on mortality and morbidity. Am J Respir Crit Care Med 1996; 154: 91-97
  • 12 Meduri GU, Mauldin GL, Wunderink GR et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest 1994; 106: 221-235
  • 13 Klompas M. Does this patient have ventilator-associated pneumonia?. JAMA 2007; 297: 1583-1593
  • 14 Meersseman W, Lagrou K, Spriet I et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009; 35: 1526-1531
  • 15 Craven DE, Kunches LM, Lichtenberg DA et al. Nosocomial infection and fatality in medical and surgical intensive care unit patients. Arch Intern Med 1988; 148: 1161-1168
  • 16 Cross AS, Roup B. Role of respiratory assistance devices in endemic nosocomial pneumonia. Am J Med 1981; 70: 681-685
  • 17 Haley RW, Hooton TM, Culver DH et al. Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med 1981; 70: 947-959
  • 18 Zanella A, Scaravilli V, Isgròet S et al. Fluid leakage across tracheal tube cuff, effect of different cuff material, shape, and positive expiratory pressure: a bench-top study. Intensive Care Med 2011; 37: 343-347
  • 19 Loftus RW, Muffly MK, Brown JR et al. Hand contamination of anesthesia providers is an important risk factor for intraoperative bacterial transmission. Anesth Analg 2011; 112: 98-105
  • 20 Semmelweis I. The etiology, concept and prophylaxis of childbed fever. Med Hist 1984; 28: 334-334
  • 21 Pittet D, Hugonnet S, Harbarth S et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection Control Programme. Lancet 2000; 356: 1307-1312
  • 22 Koff MD, Corwin HL, Beach ML et al. Reduction in ventilator associated pneumonia in a mixed intensive care unit after initiation of a novel hand hygiene program. J Crit Care DOI: 10.1016/j.jcrc.2010.12.013. 2011;
  • 23 Rello J, Lode H, Cornaglia G, Masterton R. A European care bundle for prevention of ventilator-associated pneumonia. Intensive Care Med 2010; 36: 773-780
  • 24 Garcia R, Jendresky L, Colbert L et al. Reducing ventilator-associated pneumonia through advanced oral-dental care: a 48-month study. Am J Crit Care 2009; 18: 523-532
  • 25 Mori H, Hirasawa H, Oda S et al. Oral care reduces incidence of ventilator-associated pneumonia in ICU populations. Intensive Care Med 2006; 32: 230-236
  • 26 Sona CS, Zack JE, Schallom ME et al. The impact of a simple, low-cost oral care protocol on ventilator-associated pneumonia rates in a surgical intensive care unit. J Intensive Care Med 2009; 24: 54-62
  • 27 Chan EY, Ruest A, Meade MO, Cook DJ. Oral decontamination for prevention of pneumonia in mechanically ventilated adults: systematic review and meta-analysis. BMJ 2007; 334: 889-889
  • 28 Bonten MJ, Kullberg BJ, van Dalen R et al. Selective digestive decontamination in patients in intensive care. The Dutch Working Group on Antibiotic Policy. J Antimicrob Chemother 2000; 46: 351-362
  • 29 Stoutenbeek CP, van Saene HK, Miranda DR, Zandstra DF. The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 1984; 10: 185-192
  • 30 Nathens AB, Marshall JC. Selective decontamination of the digestive tract in surgical patients: a systematic review of the evidence. Arch Surg 1999; 134: 170-176
  • 31 Krueger WA, Lenhart FP, Neeser G et al. Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients: a prospective, stratified, randomized, double-blind, placebo-controlled clinical trial. Am J Respir Crit Care Med 2002; 166: 1029-1037
  • 32 de Smet AMGA, Kluytmans JAJW, Cooper BS et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360: 20-31
  • 33 Ewig S, Torres A, el-Ebiary M et al. Bacterial colonization patterns in mechanically ventilated patients with traumatic and medical head injury. Incidence, risk factors, and association with ventilator-associated pneumonia. Am J Respir Crit Care Med 1999; 159: 188-198
  • 34 Oostdijk EAN, de Smet AMGA, Blok HEM et al. Ecological effects of selective decontamination on resistant gram-negative bacterial colonization. Am J Respir Crit Care Med 2010; 181: 452-457
  • 35 Dezfulian C, Shojania K, Collard HR et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 2005; 118: 11-18
  • 36 Lorente L, Lecuona M, Jiménez A et al. Influence of an endotracheal tube with polyurethane cuff and subglottic secretion drainage on pneumonia. Am J Respir Crit Care Med 2007; 176: 1079-1083
  • 37 Miller MA, Arndt JL, Konkle MA et al. A polyurethane cuffed endotracheal tube is associated with decreased rates of ventilator-associated pneumonia. J Crit Care 2010; 26: 280-286
  • 38 Poelaert J, Depuydt P, de Wolf A et al. Polyurethane cuffed endotracheal tubes to prevent early postoperative pneumonia after cardiac surgery: a pilot study. J Thorac Cardiovasc Surg 2008; 135: 771-776
  • 39 Valencia M, Ferrer M, Farre R et al. Automatic control of tracheal tube cuff pressure in ventilated patients in semirecumbent position: a randomized trial. Crit Care Med 2007; 35: 1543-1549
  • 40 Kollef MH, Afessa B, Anzueto A et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2009; 300: 805-813
  • 41 Kolobow T, Berra L, Li Bassi G, Curto F. Novel system for complete removal of secretions within the endotracheal tube: the Mucus Shaver. Anesthesiology 2005; 102: 1063-1065
  • 42 Berra L, Curto F, Li BG et al. Antibacterial-coated tracheal tubes cleaned with the Mucus Shaver: a novel method to retain long-term bactericidal activity of coated tracheal tubes. Intensive Care Med 2006; 32: 888-893
  • 43 Subirana M, Solà I, Benito S. Closed tracheal suction systems versus open tracheal suction systems for mechanically ventilated adult patients. Cochrane Database Syst Rev Art.No.: CD004581 DOI: 10.1002/14651858.CD004581.pub. 2007; 4
  • 44 Jongerden IP, Buiting AG, Leverstein-van Hall MA et al. Effect of open and closed endotracheal suctioning on cross-transmission with Gram-negative bacteria: A prospective crossover study. Crit Care Med 10.1097/CCM.0b013e3182120815 2011; 39
  • 45 Ricard JD, Eveillard M, Martin Y et al. Influence of tracheal suctioning systems on health care workers' gloves and equipment contamination: A comparison of closed and open systems. Am J Infect Control DOI: 10.1016/j.ajic.2010.10.031. 2011;
  • 46 Cobley M, Atkins M, Jones PL. Environmental contamination during tracheal suction. A comparison of disposable conventional catheters with a multiple-use closed system device. Anaesthesia 1991; 46: 957-961
  • 47 Drakulovic MB, Torres A, Bauer TT et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet 1999; 354: 1851-1858
  • 48 van Nieuwenhoven CA, Christianne A, Vandenbroucke-Grauls C et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit. Care Med 2006; 34: 396-402
  • 49 Hillman KM, Riordan T, O'Farrell SM, Tabaqchali S. Colonization of the gastric contents in critically ill patients. Crit Care Med 1982; 10: 444-447
  • 50 Cook DJ, Fuller HD, Guyatt GH et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994; 330: 377-381
  • 51 Faisy C, Guerot E, Diehl JL et al. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress-ulcer prophylaxis. Intensive Care Med 2003; 29: 1306-1313
  • 52 Marik PE, Vasu T, Hirani A, Pachinburavan M. Stress ulcer prophylaxis in the new millennium: a systematic review and meta-analysis. Crit Care Med 2010; 38-38
  • 53 Heyland DK, Drover JW, Dhaliwal R, Greenwood J. Optimizing the benefits and minimizing the risks of enteral nutrition in the critically ill: role of small bowel feeding. JPEN J Parenter Enteral Nutr discussion S 2002; 26: 56-57
  • 54 Marik PE, Zaloga GP. Gastric versus post-pyloric feeding: a systematic review. Crit Care 2003; 7: 46-51
  • 55 Guerin C, Gaillard S, Lemasson S et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004; 292: 2379-2387
  • 56 Voggenreiter G, Aufmkolk M, Stiletto RJ et al. Prone positioning improves oxy-genation in post-traumatic lung injury–a prospective randomized trial. J Trauma 2005; 59: 341-343
  • 57 Tiruvoipati R, Bangash M, Manktelow B, Peek GJ. Efficacy of prone ventilation in adult patients with acute respiratory failure: a meta-analysis. J Crit Care 2008;
  • 58 Manzano F, Fernández-Mondéjar E, Colmenero M. et al. Positive-end expiratory pressure reduces incidence of ventilator-associated pneumonia in nonhypoxemic patients. Crit Care Med 2008; 36: 2225-2231
  • 59 Nourdine K, Combes P, Carton MJ et al. Does noninvasive ventilation reduce the ICU nosocomial infection risk? A prospective clinical survey. Intensive Care Med 1999; 25: 567-573
  • 60 Ferrer M, Sellarés J, Valencia M et al. Non-invasive ventilation after extubation in hypercapnic patients with chronic respiratory disorders: randomised controlled trial. Lancet 2009; 374: 1082-1088
  • 61 Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med 2000; 342: 1471-1477
  • 62 Girard TD, Kress JP, Fuchs BD et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008; 371: 126-134
  • 63 Marelich GP, Murin S, Battistella F et al. Protocol weaning of mechanical ventilation in medical and surgical patients by respiratory care practitioners and nurses: effect on weaning time and incidence of ventilator-associated pneumonia. Chest 2000; 118: 459-467
  • 64 Lellouche F, Mancebo J, Jolliet P et al. A multicenter randomized trial of computer-driven protocolized weaning from mechanical ventilation. Am J Respir Crit Care Med 2006; 174: 894-900
  • 65 Apisarnthanarak A, Pinitchai U, Thongphubeth K et al. Effectiveness of an edu-cational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis 2007; 45: 704-711
  • 66 Salahuddin N, Zafar A, Sukhyani L et al. Reducing ventilator-associated pneumonia rates through a staff education programme. J Hosp Infect 2004; 57: 223-227
  • 67 Zack JE, Garrison T, Trovillion E et al. Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia. Crit Care Med 2002; 30: 2407-2412
  • 68 Babcock HM, Zack JE, Garrison T et al. An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. Chest 2004; 125: 2224-2231
  • 69 Burger CD, Resar RK. ”Ventilator bundle“ approach to prevention of ventilator-associated pneumonia. Mayo Clin Proc 2006; 81: 849-850
  • 70 Resar R, Pronovost P, Haraden C et al. Using a bundle approach to improve ventilator care processes and reduce ventilator-associated pneumonia. Jt Comm J Qual Patient Saf 2005; 31: 243-248
  • 71 Berriel-Cass D, Adkins FW, Jones P, Fakih MG. Eliminating nosocomial infections at Ascension Health. Jt Comm J Qual Patient Saf 2006; 32: 612-620
  • 72 Youngquist P, Carroll M, Farber M et al. Implementing a ventilator bundle in a community hospital. Jt Comm J Qual Patient Saf 2007; 33: 73-73
  • 73 Koff MD, Corwin HL, Beach ML et al. Reduction in ventilator associated pneumonia in a mixed intensive care unit after initiation of a novel hand hygiene program. J Crit Care DOI: 10.1016/j.jcrc.2010.12.013. 2011;
  • 74 Tablan OC, Anderson LJ, Besser R et al. Guidelines for preventing health-care – associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 2004; 53-53
  • 75 Coffin SE et al. Strategies to prevent ventilator-associated pneumonia in acute care hospitals. Infect Control Hosp Epidemiol (Suppl. 01) 2009; 29: 31-40
  • 76 Han J, Liu Y. Effect of ventilator circuit changes on ventilator-associated pneumonia: a systematic review and meta-analysis. Respir Care 2010; 55: 467-474
  • 77 Delclaux C et al. Treatment of acute hypoxemic nonhypercapnic respiratory insufficiency with continuous positive airway pressure delivered by a face mask: a randomized controlled trial. JAMA 2000; 284: 2352-2360
  • 78 Guérin C, Girard R, Chemorin C et al. Facial mask noninvasive mechanical ventilation reduces the incidence of nosocomial pneumonia. A prospective epidemiological survey from a single ICU. Intensive Care Med 1997; 23-23